Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...
StockStory.org on MSN
Why is PacBio (PACB) stock soaring today?
The previous big move we wrote about was 1 day ago when the stock dropped 3.1% on the news that the Trump administration's ...
Pacific Biosciences of California Inc. (NASDAQ:PACB) on Wednesday announced preliminary revenue of $36.9 million versus a consensus of $33.49 million. The company said the first quarter met ...
The latest update pegs Pacific Biosciences of California’s fair value at US$2.50 per share, compared with the prior US$2.42 anchor, giving investors a fresh reference point for the story. Analysts are ...
StockStory.org on MSN
5 must-read analyst questions from PacBio’s Q4 earnings call
Pacific Biosciences’ fourth quarter results exceeded Wall Street’s expectations, supported by record consumables revenue and ...
(RTTNews) - Pacific Biosciences of California, Inc.(PACB), a biotechnology-based sequencing solutions manufacturer, reported fourth-quarter and full-year 2025 results with a narrowed adjusted net loss ...
Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. Speaking on its strategic developments and challenges, Pacific Biosciences of California (NASDAQ:PACB) ...
Good afternoon, everyone. And welcome to the PacBio First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there ...
SAN DIEGO & MENLO PARK, Calif.--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results